Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PROSTATE CARCINOMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 603 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bankert, RB; Egilmez, NK; Hess, SD
      Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies

      TRENDS IN IMMUNOLOGY
    2. Herbst, RS; Kim, ES; Harari, PM
      IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer

      EXPERT OPINION ON BIOLOGICAL THERAPY
    3. Goddard, JC; Sutton, CD; Berry, DP; O'Byrne, KJ; Kockelbergh, RC
      The use of microvessel density in assessing human urological tumours

      BJU INTERNATIONAL
    4. Romaneehsen, B; Anders, M; Rohrl, B; Hast, HJ; Hengstler, JG; Schiffer, I; Neugebauer, B; Teichmann, E; Schreiber, WG; Thelen, M
      Cryotherapy of malignant tumors. MR imaging in comparison with pathological changes in mice

      ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    5. Beerlage, HP; Aarnink, RG; Ruijter, ET; Witjes, JA; Wijkstra, H; van de Kaa, CA; Debruyne, FMJ; de la Rosette, JJMCH
      Correlation of transrectal ultrasound, computer analysis of transrectal ultrasound and histopathology of radical prostatectomy specimen

      PROSTATE CANCER AND PROSTATIC DISEASES
    6. Kassis, J; Lauffenburger, DA; Turner, T; Wells, A
      Tumor invasion as dysregulated cell motility

      SEMINARS IN CANCER BIOLOGY
    7. Paquin, A; Jaalouk, DE; Galipeau, J
      Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for celland gene therapy applications

      HUMAN GENE THERAPY
    8. Inoue, K; Wood, CG; Slaton, JW; Karashima, T; Sweeney, P; Dinney, CPN
      Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8

      ONCOLOGY REPORTS
    9. Ahn, KS; Jung, YS; Kim, J; Lee, H; Yoon, SS
      Behavior of murine renal carcinoma cells crown in ectopic or orthotopic sites in syngeneic mice

      TUMOR BIOLOGY
    10. Crabtree, DV; Ojima, I; Geng, XD; Adler, AJ
      Tubulins in the primate retina: Evidence that xanthophylls may be endogenous ligands for the paclitaxel-binding site

      BIOORGANIC & MEDICINAL CHEMISTRY
    11. Jeanty, P; Sleurs, E; Bircher, AM; Valero, G
      Knowledge, education, research and the Web

      ULTRASOUND IN OBSTETRICS & GYNECOLOGY
    12. Foster, JR
      The functions of cytokines and their uses in toxicology

      INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
    13. Ip, SM; Huang, TG; Yeung, WSB; Ngan, HYS
      pRb-expressing adenovirus Ad5-Rb attenuates the p53-induced apoptosis in cervical cancer cell lines

      EUROPEAN JOURNAL OF CANCER
    14. Kido, S; Kitadai, Y; Hattori, N; Haruma, K; Kido, T; Ohta, M; Tanaka, S; Yoshihara, M; Sumii, K; Ohmoto, Y; Chayama, K
      Interleukin 8 and vascular endothelial growth factor - prognostic factors in human gastric carcinomas?

      EUROPEAN JOURNAL OF CANCER
    15. Windsor, PM
      Predictors of response to strontium-89 (Metastron (R)) in skeletal metastases from prostate cancer: Report of a single centre's 10-year experience

      CLINICAL ONCOLOGY
    16. Bollito, E; Berruti, A; Bellina, A; Mosca, A; Leonardo, E; Tarabuzzi, R; Cappia, S; Mari, M; Tampellini, M; Fontana, D; Gubetta, L; Angeli, A; Dogliotti, L
      Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma

      ANNALS OF ONCOLOGY
    17. Yamazaki, T; Suzuki, H; Tobe, T; Sekita, N; Kito, H; Ichikawa, T; Akakura, K; Igarashi, T; Ito, H
      Prostate adenocarcinoma producing syndrome of inappropriate secretion of antidiuretic hormone

      INTERNATIONAL JOURNAL OF UROLOGY
    18. Nagakawa, O; Ogasawara, M; Murata, J; Fuse, H; Saiki, I
      Effect of prostatic neuropeptides on migration of prostate cancer cell lines

      INTERNATIONAL JOURNAL OF UROLOGY
    19. Calaluce, R; Kunkel, MW; Watts, GS; Schmelz, M; Hao, JS; Barrera, J; Gleason-Guzman, M; Isett, R; Fitchmun, M; Bowden, GT; Cress, AE; Futscher, BW; Nagle, RB
      Laminin-5-mediated gene expression in human prostate carcinoma cells

      MOLECULAR CARCINOGENESIS
    20. Lezama, R; Castillo, A; Luduena, RF; Meza, I
      Over-expression of beta I tubulin in MDCK cells and incorporation of exogenous beta I tubulin into microtubules interferes with adhesion and spreading

      CELL MOTILITY AND THE CYTOSKELETON
    21. Sun, SS; Tsai, SC; Hsieh, JF; Lee, JK; Kao, CH
      Discrepancy between clinical symptoms and Tc-99m MDP bone scan findings before and after strontium-89 therapy for metastatic bone pain of prostate carcinoma

      CLINICAL NUCLEAR MEDICINE
    22. Yuksel, M; Cermik, TF; Kaya, M; Salan, A; Ustun, F; Salihoglu, YS; Yigitbasi, ON; Berkarda, S
      Extensive bone metastases in a patient with prostatic adenocarcinoma and normal serum prostate-specific antigen and prostatic acid phosphatase

      CLINICAL NUCLEAR MEDICINE
    23. Farmer, KD; Gellett, LR; Vivian, GC; Franklin, K
      Bladder diverticulum simulating a pelvic metastasis on a Tc-99m HDP bone scan

      CLINICAL NUCLEAR MEDICINE
    24. Pilepich, MV; Winter, K; John, MJ; Mesic, JB; Sause, W; Rubin, P; Lawton, C; Machtay, M; Grignon, D
      Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    25. Perez, CA; Michalski, JM; Lockett, MA
      Chemical disease-free survival in localized carcinoma of prostate treated with external beam irradiation: Comparison of American Society of Therapeutic Radiology and Oncology Consensus or 1 ng/ml as endpoint

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    26. Lawton, CA; Winter, K; Murray, K; Machtay, M; Mesic, JB; Hanks, GE; Coughlin, CT; Pilepich, MV
      Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    27. Pepper, MS
      Extracellular proteolysis and angiogenesis

      THROMBOSIS AND HAEMOSTASIS
    28. Thuroff, S; Chaussy, C
      Therapy of localized prostate cancer with high-intensity focused ultrasound. Results and side effects

      UROLOGE A
    29. Holm, R; Skovlund, E; Skomedal, H; Florenes, VA; Tanum, G
      Reduced expression of p21(WAF1) is an indicator of malignant behaviour in anal carcinomas

      HISTOPATHOLOGY
    30. Jordan, A; Scholz, R; Maier-Hauff, K; Johannsen, M; Wust, P; Nadobny, J; Schirra, H; Schmidt, H; Deger, S; Loening, S; Lanksch, W; Felix, R
      Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia

      JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
    31. Burkhart, CA; Kavallaris, M; Horwitz, SB
      The role of beta-tubulin isotypes in resistance to antimitotic drugs

      BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    32. Sedelaar, JPM; van Leenders, GJLH; Hulsbergen-van de Kaa, CA; van der Poel, HG; van der Laak, JAWM; Debruyne, FMJ; Wijkstra, H; de la Rosette, JJMCH
      Microvessel density: Correlation between contrast ultrasonography and histology of prostate cancer

      EUROPEAN UROLOGY
    33. Oyen, WJG; Witjes, JA; Corstens, FHM
      Nuclear medicine techniques for the diagnosis and therapy of prostate carcinoma

      EUROPEAN UROLOGY
    34. Bossink, AWJ; Rabe, KF
      A refugee with a supraclavicular lymph node - An uncommon first presentation of carcinoma of the prostate

      NETHERLANDS JOURNAL OF MEDICINE
    35. Movsas, B; Chapman, JD; Hanlon, AL; Horwitz, EM; Pinover, WH; Greenberg, RE; Stobbe, C; Hanks, GE
      Hypoxia in human prostate carcinoma - An Eppendorf Po-2 study

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    36. Szende, B; Romics, I; Minik, K; Szabo, J; Torda, I; Lovasz, S; Szomor, L; Toth, L; Bely, M; Kerenyi, T; Bartok, K; Vegh, A
      Repeated biopsies in evaluation of therapeutic effects in prostate carcinoma

      PROSTATE
    37. Stratton, MS; Sirvent, H; Udayakumar, TS; Nagle, RB; Bowden, GT
      Expression of the matrix metalloproteinase promatrilysin in coculture of prostate carcinoma cell lines

      PROSTATE
    38. Schmidt, U; Fiedler, U; Pilarsky, CP; Ehlers, W; Fussel, S; Haase, M; Faller, G; Sauter, G; Wirth, MP
      Identification of a novel gene on chromosome 13 between BRCA-2 and RB-1

      PROSTATE
    39. Chan, FL; Choi, HL; Ho, SM
      Analysis of glycoconjugate patterns of normal and hormone-induced dysplastic noble rat prostates, and an androgen-independent noble rat prostate tumor, by lectin histochemistry and protein blotting

      PROSTATE
    40. Strohmeyer, D; Frauscher, F; Klauser, A; Recheis, W; Rogatsch, H; Eibl, G; Horninger, W; Steiner, H; Volgger, H; Bartsch, G
      Contrast-enhanced Transrectal Color Doppler Ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer

      ANTICANCER RESEARCH
    41. Culp, LA; Holleran, JL; Miller, CJ
      Tracking prostate carcinoma micrometastasis to multiple organs using histochemical marker genes and novel cell systems

      HISTOLOGY AND HISTOPATHOLOGY
    42. Rekasi, Z; Varga, JL; Schally, AV; Plonowski, A; Halmos, G; Csernus, B; Armatis, P; Groot, K
      Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways

      PEPTIDES
    43. Chatzistamou, I; Schally, AV; Varga, JL; Groot, K; Armatis, P; Bajo, AM
      Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    44. Satish, PR; Surolia, A
      Exploiting lectin affinity chromatography in clinical diagnosis

      JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
    45. Serafini, AN
      Therapy of metastatic bone pain

      JOURNAL OF NUCLEAR MEDICINE
    46. Jiang, Z; Woda, BA; Rock, KL; Xu, YD; Savas, L; Khan, A; Pihan, G; Cai, F; Babcook, JS; Rathanaswami, P; Reed, SG; Xu, JC; Fanger, GR
      P504S - A new molecular marker for the detection of prostate carcinoma

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    47. Maru, N; Ohori, M; Kattan, MW; Scardino, PT; Wheeler, TM
      Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens

      HUMAN PATHOLOGY
    48. Supino, R; Polizzi, D; Pavesi, R; Pratesi, G; Guano, F; Capranico, G; Palumbo, M; Sissi, C; Richter, S; Beggiolin, G; Menta, E; Pezzoni, G; Spinelli, S; Torriani, D; Carenini, N; Dal Bo, L; Facchinetti, F; Tortereto, M; Zunino, F
      A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts

      ONCOLOGY
    49. Mendelsohn, J; Dinney, CPN
      The Willet F. Whitmore, Jr., lectureship: Blockade of epidermal growth factor receptors as anticancer therapy

      JOURNAL OF UROLOGY
    50. Vaidya, A; Soloway, MS; Hawke, C; Tiguert, R; Civantos, F
      De novo muscle invasive bladder cancer: Is there a change in trend?

      JOURNAL OF UROLOGY
    51. van den Brule, FA; Waltregny, D; Castronovo, V
      Increased expression of galectin-I in carcinoma-associated stroma predictspoor outcome in prostate carcinoma patients

      JOURNAL OF PATHOLOGY
    52. Riesenberg, R; Buchner, A; Pohla, H; Lindhofer, H
      Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (alpha EpCAM x alpha CD3)

      JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
    53. Swindle, CS; Tian, KT; Johnson, TD; Banerjee, P; Mayes, AM; Griffith, L; Wells, A
      Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor

      JOURNAL OF CELL BIOLOGY
    54. Colombo, P; Patriarca, C; Alfano, RM; Cassani, B; Grimaldi, GC; Roncalli, M; Bosari, S; Coggi, G; Campo, B; Gould, VE
      Molecular disorders in transitional vs. peripheral zone prostate adenocarcinoma

      INTERNATIONAL JOURNAL OF CANCER
    55. Bair, EL; Massey, CP; Tran, NL; Borchers, AH; Heimark, RL; Cress, AE; Bowden, GT
      Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in clocultures of malignant oral squamous cell carcinoma cells anddermal fibroblasts

      EXPERIMENTAL CELL RESEARCH
    56. Fitts, JM; Klein, RM; Powers, CA
      Estrogen and tamoxifen interplay with T-3 in male rats: Pharmacologically distinct classes of estrogen responses affecting growth, bone, and lipid metabolism, and their relation to serum GH and IGF-I

      ENDOCRINOLOGY
    57. Song, SH; Wientjes, MG; Walsh, C; Au, JLS
      Nontoxic doses of suramin enhance activity of paclitaxel against lung metastases

      CANCER RESEARCH
    58. Kavallaris, M; Tait, AS; Walsh, BJ; He, LF; Horwitz, SB; Norris, MD; Haber, M
      Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells

      CANCER RESEARCH
    59. Jing, C; Beesley, C; Foster, CS; Chen, HJ; Rudland, PS; West, DC; Fujii, H; Smith, PH; Ke, YQ
      Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells

      CANCER RESEARCH
    60. Shono, T; Tofilon, PJ; Bruner, JM; Owolabi, O; Lang, FF
      Cyclooxygenase-2 expression in human gliomas: Prognostic significance and molecular correlations

      CANCER RESEARCH
    61. Coffey, RNT; Watson, RWG; Hegarty, PK; Watson, CL; Wolohan, L; Brady, HR; O'Keane, C; Fitzpatrick, JM
      Priming prostate carcinoma cells for increased apoptosis is associated with up-regulation of the caspases

      CANCER
    62. Demers, RY; Tiwari, A; Wei, J; Weiss, LK; Severson, RK; Montie, J
      Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality

      CANCER
    63. Calvo, E; Cortes, J; Rodriguez, J; Sureda, M; Beltran, U; Rebollo, J; Martinez-Monge, R; Berian, JM; de Irala, J; Brugarolas, A
      Fixed higher dose schedule of suramin plus hydrocortisone in patients withhormone refractory prostate carcinoma - A multicenter phase II study

      CANCER
    64. Nojima, D; Li, LC; Dharia, A; Perinchery, G; Ribeiro, L; Yen, TSB; Dahiya, R
      CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma

      CANCER
    65. Santen, RJ; Petroni, GR; Fisch, MJ; Myers, CE; Theodorescu, D; Cohen, RB
      Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma

      CANCER
    66. Kato, I; Severson, RK; Schwartz, AG
      Conditional median survival of patients with advanced carcinoma - Surveillance, epidemiology, and end results data

      CANCER
    67. Liu, BCS; LaRose, I; Weinstein, LJ; Ahn, M; Weinstein, MH; Richie, JP
      Expression of telomerase subunits in normal and neoplastic prostate epithelial cells isolated by laser capture microdissection

      CANCER
    68. Diamond, TH; Winters, J; Smith, A; De Souza, P; Kersley, JH; Lynch, WJ; Bryant, C
      The anti osteo porotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade - A double blind, randomized, placebo-controlled crossover study

      CANCER
    69. Eton, DT; Lepore, SJ; Helgeson, VS
      Early quality of life in patients with localized prostate carcinoma - An examination of treatment-related, demographic, and psychosocial factors

      CANCER
    70. Francini, G; Petrioli, R; Gonnelli, S; Correale, P; Pozzessere, D; Marsili, S; Montagnani, A; Lucani, B; Rossi, S; Monaco, R; Manganelli, A; Salvestrini, F; Fiaschi, AI
      Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma

      CANCER
    71. Latil, AG; Azzouzi, R; Cancel, GS; Guillaume, EC; Cochan-Priollet, B; Berthon, PL; Cussenot, O
      Prostate carcinoma risk and allelic variants of genes involved in androgenbiosynthesis and metabolism pathways

      CANCER
    72. Beilin, J; Harewood, L; Frydenberg, M; Mameghan, H; Martyres, RF; Farish, SJ; Yue, C; Deam, DR; Byron, KA; Zajac, JD
      A case-control study of the androgen receptor gene CAG repeat polymorphismin Australian prostate carcinoma subjects

      CANCER
    73. Bayley, A; Milosevic, M; Blend, R; Logue, J; Gospodarowicz, M; Boxen, I; Warde, P; McLean, M; Catton, C; Catton, P
      A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinoma

      CANCER
    74. Lilleby, W; Torlakovic, G; Torlakovic, E; Skovlund, E; Fossa, SD
      Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy

      CANCER
    75. Ruchlin, HS; Pellissier, JM
      An economic overview of prostate carcinoma

      CANCER
    76. Riley, DE; Krieger, JN
      Short tandem repeat polymorphism linkage to the androgen receptor gene in prostate carcinoma

      CANCER
    77. Paquette, EL; Connelly, RR; Sesterhenn, IA; Zhang, W; Sun, L; Paquette, LR; Greenspan, R; McLeod, DG; Moul, JW
      Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era - Implications for screening a high-risk group for prostate carcinoma

      CANCER
    78. Ziada, AM; Lisle, TC; Snow, PB; Levine, RF; Miller, G; Crawford, ED
      Impact of different variables on the outcome of patients with clinically confined prostate carcinoma - Prediction of pathologic stage and biochemicalfailure using an artificial neural network

      CANCER
    79. Han, M; Snow, PB; Brandt, JM; Partin, AW
      Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma

      CANCER
    80. Horninger, W; Bartsch, G; Snow, PB; Brandt, JM; Partin, AW
      The problem of cutoff levels in a screened population - Appropriateness ofinforming screenees about their risk of having prostate carcinoma

      CANCER
    81. Babaian, RJ; Troncoso, P; Bhadkamkar, VA; Johnston, DA
      Analysis of clinicopathologic factors predicting outcome after radical prostatectomy

      CANCER
    82. Gupta, S; Srivastava, M; Ahmad, N; Sakamoto, K; Bostwick, DG; Mukhtar, H
      Lipoxygenase-5 is overexpressed in prostate adenocarcinoma

      CANCER
    83. Ito, K; Kubota, Y; Yamamoto, T; Suzuki, K; Fukabori, Y; Kurokawa, K; Yamanaka, H
      Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/mL or less

      CANCER
    84. Sherman, EJ; Pfister, DG; Ruchlin, HS; Rubin, DM; Radzyner, MH; Kelleher, GH; Slovin, SF; Kelly, WK; Scher, HI
      The collection of indirect and nonmedical direct costs (COIN) form - A newtool for collecting the invisible costs of androgen independent prostate carcinoma

      CANCER
    85. Takimoto, Y; Shimazui, T; Akaza, H; Sato, N; Noguchi, M
      Genetic heterogeneity of surgically resected prostate carcinomas and theirbiopsy specimens is related to their histologic differentiation

      CANCER
    86. Veltri, RW; Miller, MC; Partin, AW; Poole, EC; O'Dowd, GJ
      Prediction of prostate carcinoma stage by quantitative biopsy pathology

      CANCER
    87. Ferrari, AC; Chachoua, A; Singh, H; Rosenthal, M; Taneja, S; Bednar, M; Mandeli, J; Muggia, F
      A phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma

      CANCER
    88. Munshi, HG; Pienta, KJ; Smith, DC
      Chemotherapy in patients with prostate specific antigen-only disease afterprimary therapy for prostate carcinoma - A Phase II trial of oral estramustine and oral etoposide

      CANCER
    89. Sebo, TJ; Cheville, JC; Riehle, DL; Lohse, CM; Pankratz, VS; Myers, RP; Blute, ML; Zincke, H
      Predicting prostate carcinoma volume and stage at radical prostatectomy byassessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen - A report of 454 cases

      CANCER
    90. Daniell, HW; Clark, JC; Pereira, SE; Niazi, ZA; Ferguson, DW; Dunn, SR; Figueroa, ML; Stratte, PT
      Hypogonadism following prostate-bed radiation therapy for prostate carcinoma

      CANCER
    91. Cheng, L; Zincke, H; Blute, ML; Bergstralh, EJ; Scherer, D; Bostwick, DG
      Risk of prostate carcinoma death in patients with lymph node metastasis

      CANCER CYTOPATHOLOGY
    92. Cheng, L; Zincke, H; Blute, ML; Bergstralh, EJ; Scherer, B; Bostwick, DG
      Risk of prostate carcinoma death in patients with lymph node metastasis

      CANCER
    93. Ashford, AR; Albert, SM; Hoke, G; Cushman, LF; Miller, DS; Bassett, M
      Prostate carcinoma knowledge, attitudes, and screening behavior among African-American men in Central Harlem, New York City

      CANCER
    94. Ashford, AR; Albert, SM; Hoke, G; Cushman, LF; Miller, DS; Bassett, M
      Prostate carcinoma knowledge, attitudes, and screening behavior among African-American men in Central Harlem, New York City

      CANCER CYTOPATHOLOGY
    95. Miyasaka, Y; Enomoto, N; Nagayama, K; Izumi, N; Marumo, F; Watanabe, M; Sato, C
      Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization

      BRITISH JOURNAL OF CANCER
    96. Zitzelsberger, H; Engert, D; Walch, A; Kulka, U; Aubele, M; Hofler, H; Bauchinger, M; Werner, M
      Chromosomal changes during development and progression of prostate adenocarcinomas

      BRITISH JOURNAL OF CANCER
    97. Krueger, RB; Kaplan, MS
      Depot-leuprolide acetate for treatment of paraphilias: A report of twelve cases

      ARCHIVES OF SEXUAL BEHAVIOR
    98. Cheng, L; Bostwick, DG; Li, G; Zhang, SB; Vortmeyer, AO; Zhuang, ZP
      Conserved genetic findings in metastatic bladder cancer - A possible utility of allelic loss of chromosomes 9p21 and 17p13 in diagnosis

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    99. Katsetos, CD; Del Valle, L; Geddes, JF; Assimakopoulou, M; Legido, A; Boyd, JC; Balin, B; Parikh, NA; Maraziotis, T; de Chadarevian, JP; Varakis, JN; Matsas, R; Spano, A; Frankfurter, A; Herman, MM; Khalili, K
      Aberrant localization of the neuronal class III beta-tubulin in astrocytomas - A marker for anaplastic potential

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    100. Sanchenkov, A; Litvak, DA; Cabot, MC
      Targeting ceramide metabolism - a strategy for overcoming drug resistance

      JOURNAL OF THE NATIONAL CANCER INSTITUTE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/08/20 alle ore 05:31:41